Tyler-Stone Wealth Management’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-79,840
Closed -$9.58K 335
2024
Q4
$9.58K Hold
79,840
﹤0.01% 321
2024
Q3
$11K Buy
79,840
+39,920
+100% +$5.6K ﹤0.01% 319
2024
Q2
$5.84K Hold
39,920
﹤0.01% 736
2024
Q1
$5.82K Hold
39,920
﹤0.01% 734
2023
Q4
$7.99K Hold
39,920
﹤0.01% 668
2023
Q3
$7K Buy
39,920
+27,100
+211% +$5.26K ﹤0.01% 680
2023
Q2
$3K Buy
+12,820
New +$2.6K ﹤0.01% 785
2022
Q4
$2K Hold
12,820
﹤0.01% 777
2022
Q3
$3K Hold
12,820
﹤0.01% 729
2022
Q2
$3K Hold
12,820
﹤0.01% 740
2022
Q1
$4K Hold
12,820
﹤0.01% 710
2021
Q4
$4K Buy
+12,820
New +$5.77K ﹤0.01% 741

Other funds holding ZOM

Tyler-Stone Wealth Management's ZOM Position: Q1 2025 in Review

Tyler-Stone Wealth Management sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 79,840 shares — an estimated $9.58K sold.

Tyler-Stone Wealth Management first reported a position in ZOM in Q4 2021 and held it in 12 quarters. The position peaked at $11K in Q3 2024. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Tyler-Stone Wealth Management reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 79,840 Zomedica Corp. shares in Q1 2025, an estimated $9.58K.
  • Tyler-Stone Wealth Management first reported a position in Zomedica Corp. in Q4 2021 and held it in 12 quarters.
  • Tyler-Stone Wealth Management's Zomedica Corp. position peaked at $11K in Q3 2024.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q1 2025, filed 13 May 2025.